S. Allen

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

Jose M Garcia, J. Friend, Suzan Allen, 2012, Supportive Care in Cancer.

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

Jose M Garcia, R. Boccia, Ying Yan, 2015, The Lancet. Oncology.

Theophylline as a systemic anti-inflammatory agent: the need for its revival as a possible adjunctive treatment for “inflammaging”

S. Allen, D. Tiwari, 2019, Biology, Engineering and Medicine.

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

Jose M Garcia, R. Boccia, Ying Yan, 2015, The Lancet. Oncology.